Discutez avec Ed

Autres

Rejoignez notre

EN

Retour



healthcare: pharmaActualités

Pour vous Marchés Économie Technologie et IA Cryptomonnaie Énergie Santé Hong Kong et Chine Finance

Pharmacie

Biotechnologie

Services de santé

Dispositifs médicaux

BioMarin beats Q2 estimates, lifts 2026 outlook on 20% revenue growth

BioMarin beats Q2 estimates, lifts 2026 outlook on 20% revenue growth

Aug 07 2026, 17:08

TransThera shares jump 14% on China approval of tinengotinib

TransThera shares jump 14% on China approval of tinengotinib

Aug 07 2026, 03:35

FDA approves Replimune's Tudriqev melanoma drug after two rejections

FDA approves Replimune's Tudriqev melanoma drug after two rejections

Aug 07 2026, 03:25

Hikma jumps 10% as H1 profit beats, brokers keep buy

Hikma jumps 10% as H1 profit beats, brokers keep buy

Aug 06 2026, 10:06

BeOne Medicines lifts 2026 outlook as Brukinsa sales jump 31%

BeOne Medicines lifts 2026 outlook as Brukinsa sales jump 31%

Aug 06 2026, 05:28

Moderna wins FDA approval for mFLUSIVA flu vaccine in adults 50+

Moderna wins FDA approval for mFLUSIVA flu vaccine in adults 50+

Aug 06 2026, 02:49

FDA approves Takeda's oveporexton, first orexin agonist for narcolepsy type 1

FDA approves Takeda's oveporexton, first orexin agonist for narcolepsy type 1

Aug 05 2026, 22:16

Lilly raises 2026 guidance as Mounjaro, Zepbound drive 48% revenue jump

Lilly raises 2026 guidance as Mounjaro, Zepbound drive 48% revenue jump

Aug 05 2026, 11:41

Gilead Q2 revenue jumps 10% as PrEP sales top $1 billion

Gilead Q2 revenue jumps 10% as PrEP sales top $1 billion

Aug 05 2026, 02:48

Novo Nordisk raises 2026 outlook after Q2 profit jumps 11%

Novo Nordisk raises 2026 outlook after Q2 profit jumps 11%

Aug 04 2026, 16:54

CRISPR Therapeutics narrows Q2 loss as Casgevy sales surge 151%

CRISPR Therapeutics narrows Q2 loss as Casgevy sales surge 151%

Aug 04 2026, 16:19

Merck raises 2026 sales forecast to $67.3B, cuts profit view

Merck raises 2026 sales forecast to $67.3B, cuts profit view

Aug 04 2026, 11:16

Regeneron faces securities suit after $11 billion melanoma trial wipeout

Regeneron faces securities suit after $11 billion melanoma trial wipeout

Aug 04 2026, 01:21

Zevra Therapeutics falls 25% as EMA rejects arimoclomol in NPC re-examination

Zevra Therapeutics falls 25% as EMA rejects arimoclomol in NPC re-examination

Aug 03 2026, 14:23

Ascletis starts Phase III obesity trial enrolling 4,600 patients

Ascletis starts Phase III obesity trial enrolling 4,600 patients

Aug 03 2026, 13:58

AstraZeneca, Bristol Myers Squibb in talks on $400 billion merger

AstraZeneca, Bristol Myers Squibb in talks on $400 billion merger

Aug 03 2026, 07:50

Sandoz settles $450 million antitrust claims with 43 US states

Sandoz settles $450 million antitrust claims with 43 US states

Aug 03 2026, 06:25

Novo Nordisk claws back into obesity race as shares climb 35%

Novo Nordisk claws back into obesity race as shares climb 35%

Aug 03 2026, 05:51

FDA approves Novartis Pluvicto, cutting prostate cancer progression risk 33%

FDA approves Novartis Pluvicto, cutting prostate cancer progression risk 33%

Jul 31 2026, 23:48

Pharming shares plunge 22% as RUCONEST sales slide 10%

Pharming shares plunge 22% as RUCONEST sales slide 10%

Jul 31 2026, 22:45

Fonctionnalités

Copilote IA pour actions et cryptomonnaies

Prédiction des prix

Suivi des collectes de fonds

Comparaison de cryptomonnaies

Markets

News

AI & Technology

Conditions d’utilisation Politique de confidentialité Plan du site

© 2026 Edgen fonctionné par